Delivery Order SPE2DB22D3004-SPE2DB24FNY79

Award Date 1/11/24
Potential Completion Date 1/12/24
Potential Value $4.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $12,307.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, with a completion date of January 19, 2024. This is a Firm Fixed Price Delivery Order contract, and no set-aside designation was used. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $4,323.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, and has a completion date of March 11, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $13,630.44 firm fixed-price delivery order is for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product. The contract has an ultimate completion date of March 11, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,137.64 firm fixed-price delivery order is for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026....
This federal contract award, valued at $5,139.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order to provide the DLA with ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, with a completion date of February 1, 2024. The contract does not have a set-aside designation, indicating it was a full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $2,058.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, with an ultimate completion date of February 29, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
This federal contract award, valued at $14,510.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product, with a completion date of May 1, 2024. The contract is a delivery order with a firm fixed-price pricing type. There is no set-aside designation mentioned for this award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $1,682.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order without any set-aside designation, indicating open competition. The contract covers the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM to support the DLA's medical supply requirements. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $4,420.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product. This award is not associated with a set-aside program and was made through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $16,047.50, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, with a performance period ending on January 11, 2024. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB24FNY79
    Delivery Order

This federal contract award, valued at $4,618.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, with a completion date of January 12, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, and it was not set aside for any specific business category.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 5/13/25, 10:09 AM